KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Change in Account Payables (2024 - 2025)

Historic Change in Account Payables for Aurinia Pharmaceuticals (AUPH) over the last 2 years, with Q3 2025 value amounting to -$1.1 million.

  • Aurinia Pharmaceuticals' Change in Account Payables fell 33714.9% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.7 million, marking a year-over-year change of. This contributed to the annual value of $860000.0 for FY2024, which is 3064.52% down from last year.
  • According to the latest figures from Q3 2025, Aurinia Pharmaceuticals' Change in Account Payables is -$1.1 million, which was down 33714.9% from -$901000.0 recorded in Q2 2025.
  • Over the past 5 years, Aurinia Pharmaceuticals' Change in Account Payables peaked at $2.7 million during Q2 2024, and registered a low of -$3.7 million during Q4 2024.